Join Business Exchange
to access the mostrelevant content for you,
filtered by like-mindedbusiness professionals.
NEW YORK - Shares of King Pharmaceuticals Inc. rose Wednesday after a Goldman Sachs analyst put the stock on a recommended list, saying King's pain drug Embeda could be approved for sale very soon. Analyst...
to access the most relevant content for you, filtered by like-minded business professionals.
About Business Exchange
Send us Feedback
©2013 Bloomberg L.P. All Rights Reserved.